Top-level management change at Romaco Holding GmbH

4 mins read

Jörg Pieper has just been appointed new CEO of Romaco with immediate effect by the Advisory Board of Romaco Holding GmbH. Truking Investment Co., Ltd, based in Changsha (China), acquired a majority interest in Romaco at the beginning of July 2017.

Jörg Pieper appointed new CEO of Romaco

Jörg Pieper (55) has just been appointed new CEO of Romaco Holding GmbH, which has its headquarters in Karlsruhe (Germany), with immediate effect. He directly succeeds Paulo Alexandre, who has left the company. The Advisory Board would like to thank Mr. Alexandre for his contribution to the firm’s expansion during the last six years.

Jörg Pieper joined Romaco Holding GmbH in 2011. As Vice President Customer Service, he was initially responsible for establishing customer service throughout the Group. In 2013, he transferred to Romaco Kilian GmbH as Managing Director, playing a major part in the tablet press manufacturer’s success story. Prior to his arrival at Romaco, Mr. Pieper held various top-level management positions at European and American corporations in the component industry and the machine building sector.


The Karlsruhe (Germany) based Romaco Group is currently undergoing a strategic realignment following the acquisition of a majority interest by the Chinese Truking Investment Co., Ltd at the beginning of July 2017.

Jörg Pieper, Romaco’s new CEO, is a proven industry expert with an in-depth knowledge of Asia — Yue Tang, Truking Chairman. 

“With him at the helm, the company will have a chance to concentrate on its core competencies and systematically strengthen the innovation capability of its seven brands.”

In his role as CEO of the Romaco Group, Mr. Pieper will be in overall charge of Sales & Customer Service, Product Management, Marketing and International Strategy Development. “We are aiming to give an entirely new meaning to the term ‘close to the customer’ and to simultaneously strengthen our service mentality”, said Mr. Pieper, CEO Romaco Group. “In the future, it will be particularly important to anticipate the needs of our customers worldwide, to enable us to respond promptly and flexibly to changing market requirements.” Carsten Strenger will remain CFO/COO of Romaco Holding GmbH with responsibility for Finance and Operations.

The Romaco Group

Romaco is a leading global supplier of Processing and Packaging equipment, predominantly for the pharmaceutical industry. Divided into three business areas, Processing, Tableting, and Packaging, the company develops engineered system solutions for the pharmaceutical market but also supplies the cosmetics, food and chemical markets. Romaco operates from four European locations with the headquarters in Karlsruhe, Germany. The company serves the multiple industries through a total of seven brands. The packaging product lines Noack, Siebler, and Bosspak are manufactured in Karlsruhe, Germany, the primary and secondary packaging brands Macofar and Promatic in Bologna, Italy. The tableting product line Kilian is produced in Cologne, Germany, while the Innojet product line in Steinen, Germany, is responsible for granulation and coating. Romaco’s product portfolio includes primary, secondary and final packaging, aseptic and non-aseptic liquid and powder filling, tablet press technologies, granulation, and coating. Over 12,000 Romaco installations are currently in operation in more than 180 countries. The company’s worldwide customer base is supplied and supported by over 550 highly skilled and committed employees.

In 2014 the Romaco Group was voted by “Wirtschaftswoche”, the prestigious German business weekly, as one of Germany’s best 50 innovators among small and medium-sized enterprises. In this corporate benchmarking contest, Romaco was named runner-up in the “Process and Packaging Machinery” category. In the “Pharmaceutical Machinery” segment, the Group was awarded the first prize.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Previous Story

Why is Due Diligence So Important in the Pharma Industry?

Next Story

Clarithromycin (Biaxin)- Potential Increased Risk of Heart Problems or Death in Patients